The Founder

Prof. Roberto Chiarle

Roberto Chiarle is professor of Pathology at the Harvard Medical School and at the University of Turin. He oversees research laboratories both at the Boston Children’s Hospital and at the Molecular Biotechnology Center (MBC) of Turin, and he's also the director of the Division of Haemolymphopathology at the European Institute of Oncology (IEO) in Milan. His expertise delves deep into investigating ALK's role in lymphoma, non-small cell lung cancer, neuroblastoma, and other types of ALK-dirven cancers. Throughout his career, he's been dedicated to unveiling the crucial mechanisms behind ALK-mediated transformation in tumors, striving to define and validate novel approaches for targeting ALK in such cancers with particular focus on immunological therapies.